![]() ![]() ![]() CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-91 For U.S.This a subreddit dedicated to posting links to Let's Play videos and talking about those videos. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. is the world's leading source for international market research reports and market data. Hoffmann-La Roche Ltd.)įor more information about this report visit Synopsis of FDA-Associated Testing Milestones Since May 2020Ĭhapter 6 Global Point of Care Diagnostics Market, by Test Type Prioritizing of OTC and At-Home Testing Solutions Regulatory Delays, Clinical Trials and Product LaunchesįDA's Contribution to COVID-19 Diagnostic Testing and Philips HealthcareĬhapter 3 Market and Technology Background Hoffmann-La Roche Ltd, Medtronic plc, Chembio Diagnostics Inc. Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategiesĬompany profiles of major players of the industry, including Abbott, Siemens Healthcare GmbH, F. The regulations and standards are strict and require substantial expertise to navigate this resulted in increased times for pre-market approval and commercialization processĪn overview of the global markets and technologies for point of care (POC) diagnostics within healthcare industryĮstimation of market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026Įvaluation of current market trends, and technological advancements within the industry and market share analysis by test type, product, end-user, and regionĬoverage of novel approaches for the POC discussion on significance of CLIA in the United States and FDA's role in POC testing and information on laser PCRĭetailed description about COVID-19 impact on MedTech and medical tourism, discussion on FDA's contribution to COVID-19 diagnostic testing and synopsis of FDA-Associated testing milestones since May 2020ĭetailed analysis of relevant R&D activities, new products launches and product enhancement in the industry, clinical trials, and discussion of regulatory elements that are affecting the future marketplace Strict healthcare standards and high regulatory barriers have a significant impact on the introduction of innovative technology. POC devices are considered by FDA as high risk and therefore require pre-market approval. ![]() POC devices are being regulated as other diagnostics devices and In-Vitro devices that are regulated by U.S. ![]() The strict regulation for approval and commercialization is the primary factor restraining the growth of the market. The increasing prevalence of diabetes and other chronic diseases is also contributing towards growth in the global market. All such innovation within the market is expected to increase the reach of POC devices to remote areas in developing and underdeveloped countries and make them pocket friendly and can be adopted by the economically challenged populace. POC tests help to enhance the management of infectious diseases, particularly in developing countries where it is difficult to access timely diagnosis due to a lack of healthcare infrastructure.įunding and grants from governments for the advancement and development of innovative products are contributing towards the adoption of innovative technologies for infectious diseases diagnosis. The major factor contributing to the growth of the POC diagnostics market is the rising prevalence of infectious diseases. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The global market for point of care diagnostics was valued at $24.8 billion in 2021. Both segments are included in this market study. POC testing is growing in both home use and POC testing near-patient applications. This study focuses on POC testing, which is one of the most active segments within the diagnostic industry. The United States is the world's largest single market for diagnostic testing. Globally, the diagnostic testing business is a multi-billion-dollar industry with intense competition and areas of high growth. 30, 2021 (GLOBE NEWSWIRE) - The "Point of Care Diagnostics: Technologies and Global Markets" report has been added to 's offering. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |